Urgoclean Ag (loose)

Marks Tey Pharmacy Verified independent store

→

UrgoClean Ag is a sterile antimicrobial wound dressing combining highly absorbent polyacrylate fibres with a silver-impregnated TLC-Ag wound-contact matrix, designed for exuding ac ute and chronic wounds that are at risk of infection or show signs of local infection. The polyabsorbent fibres continuously trap and remove exudate, slough and wound debris, while the silver ions provide broad-spectrum antimicrobial activity. This combination makes UrgoClean Ag particularly suitable for wounds requiring simultaneous cleansing, desloughing, exudate management and antimicrobial action. Key features: Antimicrobial silver wound dressing Combines desloughing and antimicrobial activity Highly absorbent polyacrylate fibres TLC-Ag Technology Contains silver sulphate Helps absorb: Wound exudate Slough Wound debris Supports autolytic debridement Helps maintain a clean wound bed Helps disrupt and manage bacterial biofilm Broad-spectrum antimicrobial activity Active against organisms including: Staphylococcus aureus MRSA Streptococcus pyogenes Pseudomonas aeruginosa Antimicrobial activity begins rapidly after application In-vitro anti-biofilm activity demonstrated for up to 7 days Helps reduce odour caused by microorganisms Maintains a moist wound-healing environment Can assist with minor wound bleeding Strong wet integrity Designed for removal in one piece Micro-adherent wound-contact surface Designed for atraumatic removal Can be cut to size Can be used under compression therapy where clinically indicated Can be adapted for appropriate cavity wounds Secondary dressing may be used where required Sterile Single use Medical device Dressing construction UrgoClean Ag consists of a sterile non-woven pad made from cohesive polyabsorbent polyacrylate fibres. The fibres are arranged parallel to the wound surface and bonded using a hot-melt process. This structure helps: Absorb exudate Bind slough and wound debris Drain unwanted material away from the wound Maintain dressing integrity Facilitate removal in one piece The polyabsorbent dressing is coated with Urgo Medical's TLC-Ag micro-adherent healing matrix. TLC-Ag contains: Lipido-colloid components Carboxymethylcellulose Silver sulphate When the dressing contacts wound exudate, the TLC-Ag matrix forms a gel and releases antimicrobial silver ions. How UrgoClean Ag works UrgoClean Ag combines three main actions. 1. Continuous wound cleansing The polyabsorbent fibres bind to slough and wound residues. As exudate is absorbed, these residues are trapped within the dressing and removed when the dressing is changed. This supports: Desloughing Wound-bed cleansing Maintenance debridement 2. Exudate management The polyacrylate fibres have a high absorption capacity and help remove excess wound fluid while limiting its spread towards the wound margins. This helps protect the surrounding skin from excessive moisture and maceration. 3. Antimicrobial and anti-biofilm action Silver ions released from the TLC-Ag matrix provide broad-spectrum antimicrobial activity. Urgo Medical reports activity against common wound organisms including: Staphylococcus aureus MRSA Streptococcus pyogenes Pseudomonas aeruginosa The combination of continuous cleansing and silver activity also helps disrupt bacterial biofilm and reduce its reformation. Suitable wound types UrgoClean Ag is indicated from the desloughing phase onwards for exuding acute and chronic wounds that are: At risk of infection, or Showing signs of local infection Suitable wounds include: Venous leg ulcers Diabetic foot ulcers Pressure ulcers / pressure injuries Burns Traumatic wounds Abrasions Post-operative / surgical wounds It is particularly useful where the wound contains: Slough Exudate Wound debris Increased bacterial burden The underlying cause of chronic wounds must also be appropriately treated. How to use UrgoClean Ag should be used under medical or appropriately qualified healthcare-professional supervision. Clean the wound with normal saline according to the wound-care protocol. If an antiseptic has previously been used, rinse the wound carefully with normal saline before applying UrgoClean Ag. Carry out mechanical debridement where clinically required. Remove the protective tabs from the dressing. Apply the micro-adherent side directly to the wound and wound edges. If necessary, cut the dressing to the required size using sterile scissors. Cover with an appropriate secondary dressing where necessary. Secure with a suitable bandage or tape. Compression therapy may be applied where clinically prescribed. Can UrgoClean Ag be cut? Yes. UrgoClean Ag can be cut with sterile scissors to adapt the dressing to the wound. The manufacturer also indicates that it can be adapted for appropriate cavity wounds, including by cutting the dressing into a spiral where clinically appropriate. Dressing changes During the active desloughing phase, Urgo Medical recommends changing UrgoClean Ag approximately: Every 1–2 days As the wound becomes cleaner, dressing-change frequency can be reduced according to: Exudate level Wound condition Infection status Clinical judgement The dressing may remain in place for up to: 7 days where clinically appropriate. Maximum treatment duration Urgo Medical specifies a maximum continuous treatment period with UrgoClean Ag of: 1 month If antimicrobial treatment is still required after this period, the wound and continued need for silver therapy should be clinically reassessed. Wound appearance during desloughing During the early desloughing phase, the wound may temporarily appear larger. This can occur because slough and non-viable tissue are progressively removed, exposing the true dimensions of the wound bed. This does not necessarily indicate wound deterioration, but the wound should continue to be clinically monitored. Minor bleeding UrgoClean Ag can help manage minor wound bleeding, particularly after: Mechanical debridement Surgical debridement However, it must not be used as a surgical sponge or to control heavy bleeding. Significant or uncontrolled bleeding requires appropriate haemostatic treatment. Infection UrgoClean Ag has antimicrobial activity and is specifically intended for wounds at risk of or showing signs of local infection. However, it does not replace appropriate systemic antibacterial treatment where this is clinically required. Seek clinical assessment if there is: Spreading redness Increasing swelling Increasing pain Purulent discharge Fever Cellulitis Rapid wound deterioration Signs of systemic infection Contraindications Do not use UrgoClean Ag: In patients with a known sensitivity to silver As a surgical sponge for heavily bleeding wounds Do not combine with: Hydrogen peroxide Organic mercury antiseptics Hexamidine antiseptics If another antiseptic has been used, rinse the wound thoroughly with normal saline before applying UrgoClean Ag. MRI Remove UrgoClean Ag before an MRI examination. The dressing should not remain on the patient during MRI scanning. Electrical monitoring Avoid direct contact between UrgoClean Ag and: ECG electrodes EEG electrodes Conductive gels used for electrical measurements Other topical treatments The simultaneous use of other locally acting wound treatments with UrgoClean Ag is not recommended unless compatibility has been specifically established. Pregnancy, breastfeeding and newborns Because specific clinical data are limited, the manufacturer does not recommend UrgoClean Ag during: Pregnancy Breastfeeding Treatment of newborn babies Treatment of premature babies unless appropriately assessed by the treating clinician. Children Clinical data concerning prolonged or repeated use of silver-containing dressings in children are limited. Use should therefore be based on appropriate professional assessment and the continued need for silver treatment should be regularly reviewed. Hyperbaric oxygen therapy UrgoClean Ag must not be used during hyperbaric oxygen therapy without an oxygen mask because its lipido-colloid components present a combustion risk. Specialist hyperbaric protocols must be followed. Handling The TLC-Ag surface may adhere to latex surgical gloves. Avoid touching the micro-adherent surface directly where possible. Sterile forceps or other appropriate handling techniques may be used. Important information UrgoClean Ag is: Sterile Individually packaged Single use only Do not: Reuse Re-sterilise Use if the sterile packaging is damaged Retain cut-off unused portions for later use Use after the stated expiry date Product type: Antimicrobial Polyabsorbent Desloughing Dressing Technology: TLC-Ag / Lipido-Colloid Silver Technology Absorbent fibres: Polyacrylate polyabsorbent fibres Antimicrobial agent: Silver sulphate / silver ions Antimicrobial: Yes Anti-biofilm activity: Yes Primary functions: Desloughing, cleansing, exudate management and antimicrobial action Suitable wound stage: From the desloughing phase Suitable for minor bleeding: Yes Can be cut: Yes Suitable under compression: Yes, where prescribed Secondary dressing: May be required Initial change frequency: Every 1–2 days during desloughing Maximum wear time: Up to 7 days Maximum recommended treatment duration: 1 month Sterile: Yes Single use: Yes Current UK sizes and codes UrgoClean Ag – 6cm × 6cm Pack size: 10 dressings Urgo product code: 551123 PIP code: 401-9774 NHS Supply Chain code: ELY609 UrgoClean Ag – 10cm × 10cm Pack size: 10 dressings Urgo product code: 552155 PIP code: 401-9782 NHS Supply Chain code: ELY610 UrgoClean Ag – 15cm × 20cm Pack size: 5 dressings Urgo product code: 551125 PIP code: 401-9790 NHS Supply Chain code: ELY611 BNF / dm+d code: 20031700054 Manufacturer: Urgo Medical / Urgo Ltd UrgoClean Ag should be selected according to wound-bed condition, exudate level and the clinical need for antimicrobial therapy. Infected, diabetic, vascular or otherwise complex wounds should be assessed and monitored by an appropriately trained healthcare professional. Product Information Leaflet Show more